Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 8 X posts from 5 X users, with an upper bound of 22,655 followers.

#JITC Research: Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells https://t.co/Y1G1qpTcg4 https://t.co/9gaGDOoki3

RT @sitcancer: #JITC Research: Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived supp…

RT @sitcancer: #JITC Research: Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived supp…

#JITC Research: Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells https://t.co/Y1G1qpTcg4 https://t.co/RjGZyS8w5H

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.